Back to News
Market Impact: 0.1
Ensysce Biosciences, Inc. Announces Leadership Transition Following December 14, 2026 Annual Meeting
Source: Nasdaq
Management & Governance
Ensysce Biosciences said board member Will Chang intends to resign as a director following the next annual stockholders’ meeting, scheduled for December 14, 2026. The article provides no reason for the planned resignation.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.05
Ticker Sentiment
ENSC-0.10
More News
- Inside the chip talent war: Trade secrets and rising Chinese rivals
- LIV Golf faces liquidation after BC Partners scraps rescue plan
- Google expands voluntary buyouts to 5 countries as AI spending fuels cost cuts
- Democrats map out an agenda to address affordability and corruption after midterm sweep
- Palantir CEO says it's pioneering an antiwar movement – while happily accepting defense dollars
- DoorDash is buying Instacart for $17 billion. Its employees can’t add Instacart staff on LinkedIn